Furthermore, these studies show that BITC induces the expression of p73 in p53-mutant breast cancer cells, disrupts the p73:mutant-p53 sequestration complex thereby releasing p73 to drive p53-network leading to tumor inhibition. Here, TP53 is linked to breast cancer.